NCT03684642 - Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | Biotech Hunter

Enrollment

908

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

October 13, 2020

Study Completion Date

November 17, 2020

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Efpeglenatide

Pharmaceutical form: solution for injection; Route of administration: SC

DRUG

Dulaglutide

Pharmaceutical form: solution for injection; Route of administration: SC

DRUG

Background therapy Metformin

Pharmaceutical form: tablet; Route of administration: oral; Dose to be kept stable throughout the study.

Trial Locations (45)

1036

Investigational Site Number 3480004, Budapest

3000

Investigational Site Number 3480005, Hatvan

4025

Investigational Site Number 3480003, Debrecen

4400

Investigational Site Number 3480002, Nyíregyháza

5700

Investigational Site Number 3480001, Gyula

12553

Investigational Site Number 8400039, New Windsor

20110

Investigational Site Number 8400049, Manassas

21050

Investigational Site Number 8040004, Vinnytsia

27215

Investigational Site Number 8400028, Burlington

28557

Investigational Site Number 8400036, Morehead City

29445

Investigational Site Number 8400014, Goose Creek

30044

Investigational Site Number 8400025, Lawrenceville

32825

Investigational Site Number 8400055, Orlando

33026

Investigational Site Number 8400041, Pembroke Pines

35211

Investigational Site Number 8400038, Birmingham

40503

Investigational Site Number 8400044, Lexington

43537

Investigational Site Number 8400013, Maumee

60077

Investigational Site Number 8400059, Skokie

75230

Investigational Site Number 8400030, Dallas

78218

Investigational Site Number 8400020, San Antonio

78229

Investigational Site Number 8400043, San Antonio

78258

Investigational Site Number 8400053, San Antonio

83642

Investigational Site Number 8400060, Meridian

84041

Investigational Site Number 8400037, Layton

85224

Investigational Site Number 8400035, Chandler

85306

Investigational Site Number 8400005, Glendale

85381

Investigational Site Number 8400054, Peoria

90057

Investigational Site Number 8400009, Los Angeles

90255

Investigational Site Number 8400057, Huntington Park

91405

Investigational Site Number 8400026, Van Nuys

91978

Investigational Site Number 8400045, Spring Valley

92120

Investigational Site Number 8400007, San Diego

92780

Investigational Site Number 8400040, Tustin

06708

Investigational Site Number 8400050, Waterbury

02115

Investigational Site Number 8400061, Boston

08302

Investigational Site Number 8400001, Bridgeton

80-382

Investigational Site Number 6160008, Gdansk

81-537

Investigational Site Number 6160004, Gdynia

40-040

Investigational Site Number 6160010, Katowice

60-702

Investigational Site Number 6160009, Poznan

01-192

Investigational Site Number 6160003, Warsaw

50-381

Investigational Site Number 6160001, Wroclaw

02002

Investigational Site Number 8040003, Kyiv

03037

Investigational Site Number 8040001, Kyiv

03049

Investigational Site Number 8040002, Kyiv